Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cour Pharmaceutical Development Company, Inc.

Clinical trials sponsored by Cour Pharmaceutical Development Company, Inc., explained in plain language.

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New hope for myasthenia gravis: experimental drug CNP-106 enters human trials

Disease control Ongoing

This study tests an experimental drug called CNP-106 in 54 adults aged 18-75 with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to check if the drug is safe and how it affects the immune system. Participants receive either CNP-106 or a placeb…

Phase: PHASE1, PHASE2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:05 UTC